InvestorsHub Logo
Followers 829
Posts 119622
Boards Moderated 14
Alias Born 09/05/2002

Re: None

Friday, 09/27/2019 9:12:28 AM

Friday, September 27, 2019 9:12:28 AM

Post# of 2959
FDA shortens approved Mavyret regimen for treatment-naïve cirrhotics to 8w for all genotypes:

https://finance.yahoo.com/news/abbvie-receives-fda-approval-mavyret-000000712.html

Mavyret is the only HCV regimen with an 8w FDA label for all treatment-naïve patients including cirrhotics.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News